APA
Alatrash G., de Lima M., Hamerschlak N., Pelosini M., Wang X., Xiao L., Kerbauy F., Chiattone A., Rondon G., Qazilbash M. H., Giralt S. A., de Padua Silva L., Hosing C., Kebriaei P., Zhang W., Nieto Y., Saliba R. M., Champlin R. E. & Andersson B. S. (20120220). Myeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life. : Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
Chicago
Alatrash Gheath, de Lima Marcos, Hamerschlak Nelson, Pelosini Matteo, Wang Xuemei, Xiao Lianchun, Kerbauy Fabio, Chiattone Alexandre, Rondon Gabriela, Qazilbash Muzaffar H, Giralt Sergio A, de Padua Silva Leandro, Hosing Chitra, Kebriaei Partow, Zhang Weiqing, Nieto Yago, Saliba Rima M, Champlin Richard E and Andersson Borje S. 20120220. Myeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life. : Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
Harvard
Alatrash G., de Lima M., Hamerschlak N., Pelosini M., Wang X., Xiao L., Kerbauy F., Chiattone A., Rondon G., Qazilbash M. H., Giralt S. A., de Padua Silva L., Hosing C., Kebriaei P., Zhang W., Nieto Y., Saliba R. M., Champlin R. E. and Andersson B. S. (20120220). Myeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life. : Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
MLA
Alatrash Gheath, de Lima Marcos, Hamerschlak Nelson, Pelosini Matteo, Wang Xuemei, Xiao Lianchun, Kerbauy Fabio, Chiattone Alexandre, Rondon Gabriela, Qazilbash Muzaffar H, Giralt Sergio A, de Padua Silva Leandro, Hosing Chitra, Kebriaei Partow, Zhang Weiqing, Nieto Yago, Saliba Rima M, Champlin Richard E and Andersson Borje S. Myeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life. : Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 20120220.